The Weekly Edge
Join free
Menu

Feed / Deals & M&A

Kalshi introduces pharmaceutical trial and approval contracts

By The Weekly Edge desk ·

Summary

iGamingToday reported that Kalshi added markets covering clinical trial results and FDA decisions. Users can trade on whether experimental medicines pass trials or obtain regulatory approval.

Why it matters

The new category extends Kalshi’s event contracts into pharmaceutical research outcomes.

Read the original at iGaming Today

EntityKalshi
TypeCompany
Entries308
Main marketsUSA, UK
Enforcement & compliance73
Licences & markets3
Deals & M&A51
Fines recorded? 35,000; USD 35,000
Latest16 Oct 2026
Entity mapUSAKalshi
Entities and relations reported in this entry and our coverage.

Request a correction / right of reply

Connected stories

Linked through shared companies, regulators and people, or one step further through the graph.

ShareLinkedInX